IPSC

Century Therapeutics, Inc.

4.51 USD
+0.35 (+8.41%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Century Therapeutics, Inc. stock is up 10% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 February’s closed higher than January.

About Century Therapeutics, Inc.

Century Therapeutics, Inc. develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, which targets CD19 for relapsed, refractory B-cell lymphoma. It is also developing a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma.